who is not a candidate for glp 1 GLP-1 nonresponders: Up to in 5 people don't lose weight GLP-1 vs. GLP-1 + GIP:

Similar findings were demonstrated by liraglutide, which was also found to exert endothelial protective properties in human vascular endothelial cells (hVECs) through inhibition of stimulated plasminogen activator inhibitor type-1 (PAI-1) and vascular adhesion molecule (VAM) expression

Amphetamines, an active ingredient in Adderall, have a risk of misuse (abuse) which can lead to dependence on the medication, serious heart conditions, and even sudden death

This is caused by shifts in hormone levels as your body adapts to lower fat mass, not by damage to reproductive organs

If it does, shifting your workout to a trough day (day six or seven of your weekly cycle) might resolve the issue without any medication changes

Nauck MA, Jensen TJ, Rosenkilde C, Calanna S, Buse JB, LEADER Publication Committee on behalf of the LEADER Trial Investigators (2018) Neoplasms reported with liraglutide or placebo in people with type 2 diabetes: results from the LEADER randomized trial